The COVID-19 pandemic brought the term "Polymerase Chain Reaction testing" into the mainstream. The PCR method is a type of ...

The vaccine plus a booster dose reduces the odds of preeclampsia by 30% and by as much as 58% in those with preexisting ...

Opportunities in the COVID-19 tests market include developing innovative products, leveraging global and regional trends, understanding competitive dynamics, and accessing country-specific regulatory ...

Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today ...

The COVID-19 pandemic brought the term "Polymerase Chain Reaction testing" into the mainstream. The PCR method is a type of nucleic acid amplification ...

Researchers have discovered in a new research that COVID-19 infection is associated with an increased risk of a subsequent diagnosis of chronic rhinosinusitis (CRS). This suggests a possible ...

Bioxytran has announced encouraging results from a randomized, double‑blind, placebo‑controlled phase 1b/2a study of its oral ...

UW Medicine is boosting its measles testing as the nationwide outbreak continues — and as Seattle prepares to welcome ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

Even years after infection, Long COVID may be quietly reshaping mental health. New research shows the emotional fallout can outlast the virus itself.